Document is current
Any future updates will be listed below
-
Authors
Archer, Kellie J.
Fu, Han
Mrózek, Krzysztof
Nicolet, Deedra
Mims, Alice S.
Uy, Geoffrey L.
Stock, Wendy
Byrd, John C.
Hiddemann, Wolfgang
Braess, Jan
Spiekermann, Karsten
Metzeler, Klaus H.
Herold, Tobias
Eisfeld, Ann-Kathrin
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00048958 at ClinicalTrials.govnct00899223 at ClinicalTrials.govDocuments that mention this clinical trial
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
https://doi.org/10.1186/s13045-024-01553-6
nct00900224 at ClinicalTrials.govDocuments that mention this clinical trial
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
https://doi.org/10.1186/s13045-024-01553-6
nct01382147 at ClinicalTrials.govDocuments that mention this clinical trial
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
https://doi.org/10.1186/s13045-024-01553-6
Documents that mention this clinical trial
Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model
https://doi.org/10.1186/s13045-024-01553-6
-
Funding
Funding for this research was provided by:
U.S. National Library of Medicine (R01LM013879)
US National Cancer Institute (P30CA016058, U10CA180882, U24CA196171, UG1CA233327, UG1CA233338)
Coleman Leukemia Research Foundation
American Society of Hematology
Leukemia Research Foundation
Leukemia and Lymphoma Society
D. Warren Brown Family Foundation
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 29 April 2024
First Online: 3 May 2024
Declarations
:
: All study protocols were approved by the Institutional Review Boards at each participating center in accordance with the Declaration of Helsinki. Each patient provided written informed consent for the research use of their specimens before enrollment.
: The authors declare that they have no competing interests.
: Not applicable.
